Site updated at Wednesday, 22 June 2016

Living with Dementia

Psychotic Symptoms

Acadia redesigns study on Parkinson’s psychosis drug

Acadia Pharmaceuticals Inc said it redesigned an ongoing late-stage study on its experimental anti-psychotic drug for Parkinson’s disease patients, and that it plans to conduct an identical study to win regulatory approval.

The redesigned study will include only patients from North America, and will exclude mildly psychotic patients, Acadia CEO Uli Hacksell said at… Acadia redesigns study on Parkinson’s psychosis drug   

Parkinson’s Disease Dementia

social support1 - vascular risk factors2 - alzheimer's association6 - adam101 - mid-stage of alzheimer's1 - alzheimer's genes1 - alcoholic encephalopathy10 - advanced dementia1 - fish oil supplements1 - neocortex1 - phosphorylated tau1 - frontal-lobe degeneration1 - huntingtin1 - alzheimer's treatments3 - synaptic loss1 - dementing illness1 - alzheimer's patients7 - alzheimer sufferer1 - dimebon1 - tavi2 - wernicke disease1 - behavioural syndrome1 - morosis1 - hearing loss1 - pre-senile dementia1 - huntington’s disease2 - uncategorized1 - cause of dementia5 - pick’s disease1 - judgment1 -